On Monday, Sirius XM Holdings Inc. (NASDAQ:SIRI)s shares declined -0.51% to $3.94.
Sirius XM Holdings Inc. (SIRI) has market value of $21.27 billion while its EPS was booked as $0.09 in the last 12 months. The stock has 5.37 billion shares outstanding while 23.80% shares of the company were owned by institutional investors. In the profitability analysis, the company has gross profit margin of 59.60% while net profit margin was 11.20%. Beta value of the company was 1.60; beta is used to measure riskiness of the security.
Sirius XM Holdings Inc., through its subsidiaries, provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, including various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and local traffic reports for 22 metropolitan markets.
Hudson City Bancorp, Inc. (NASDAQ:HCBK)s shares dropped -4.34% to $9.47.
Hudson City Bancorp, Inc. (HCBK) has beta value of 1.18. The company has the market capitalization of $5.24 billion. Return on assets ratio of the company was 0.30% while its return on equity ratio was 2.50%. ATR value of company was 0.28 while stock volatility for week was 2.56% while for month was 3.22%.
Hudson City Bancorp, Inc. serves as the holding company of its subsidiary, Hudson City Savings Bank (the Bank). The Bank is a federal stock savings bank. The Company is a community and consumer-oriented retail savings bank offering traditional deposit products, residential real estate mortgage loans and consumer loans.
At the end of Mondays trade, bluebird bio Inc (NASDAQ:BLUE)s shares dipped -4.37% to $81.83.
bluebird bio Inc (BLUE) has -21.10% return on equity value while its ROI ratio was -9.90%. The company has $3.10 billion market capitalizations and the institutional ownership was 66.40%. Its price to book ratio was 2.93. Volatility of the stock was 13.11% for the week while for the month booked as 11.36%.
bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing products based on the transformative potential of gene therapy to treat patients with severe genetic diseases and cancer. The Companys products include Lenti-D, LentiGlobin and CAR T Cells.
This article is published by www.stocksnewswire.com. The content included in this article is just for informational purposes only. Stocksnewswire.com takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.
Neither Stocksnewswire.com nor any of Stocksnewswire.com partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.
Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by Stocksnewswire.com.
Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.